The global pharmaceutical industry experienced a 24% rise in the number of Covid-19-related patent applications in Q2 2023 compared with the previous quarter. The total number of Covid-19-related grants rose by 93% in Q2 2023, according to GlobalData’s Patent Analytics. GlobalData’s COVID-19 Cross-Sector Impact – Thematic Research report helps understand how the effect of COVID-19 on pharmaceutical sector compares with 17 other key sectors, in terms of equity indices, M&A volumes, jobs index, and filings. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights COVID-19 Cross-Sector Impact - Thematic Research

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Notably, the number of Covid-19-related patent applications in the pharmaceutical industry was 663 in Q2 2023, versus 536 in the prior quarter.

The top five companies accounted for 4% of patenting activity

Analysis of patenting activity by companies shows that F. Hoffmann-La Roche filed the most Covid-19 patents within the pharmaceutical industry in Q2 2023. The company filed 7 Covid-19-related patents in the quarter, compared with 2 in the previous quarter. It was followed by Tsinghua University with 6 Covid-19 patent filings, Enanta Pharmaceuticals (5 filings), and Shanghai Institute of Materia Medica Chinese Academy of Sciences (4 filings) in Q2 2023.

Patenting activity was driven by the US with a 44% share of total patent filings

The largest share of Covid-19 related patent filings in the pharmaceutical industry in Q2 2023 was in the US with 44%, followed by China (10%) and Japan (8%). The share represented by the US was 35% higher than the 9% share it accounted for in Q1 2023.

To further understand GlobalData's analysis on COVID-19 Cross-Sector Impact - Thematic Research buy the report here.

This content was updated on 2 August 2023

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.